208 related articles for article (PubMed ID: 26911814)
1. Development and validation of a predictive model for detection of colorectal cancer in primary care by analysis of complete blood counts: a binational retrospective study.
Kinar Y; Kalkstein N; Akiva P; Levin B; Half EE; Goldshtein I; Chodick G; Shalev V
J Am Med Inform Assoc; 2016 Sep; 23(5):879-90. PubMed ID: 26911814
[TBL] [Abstract][Full Text] [Related]
2. Early Colorectal Cancer Detected by Machine Learning Model Using Gender, Age, and Complete Blood Count Data.
Hornbrook MC; Goshen R; Choman E; O'Keeffe-Rosetti M; Kinar Y; Liles EG; Rust KC
Dig Dis Sci; 2017 Oct; 62(10):2719-2727. PubMed ID: 28836087
[TBL] [Abstract][Full Text] [Related]
3. Performance analysis of a machine learning flagging system used to identify a group of individuals at a high risk for colorectal cancer.
Kinar Y; Akiva P; Choman E; Kariv R; Shalev V; Levin B; Narod SA; Goshen R
PLoS One; 2017; 12(2):e0171759. PubMed ID: 28182647
[TBL] [Abstract][Full Text] [Related]
4. Colorectal cancer screening: comparison of transferrin and immuno fecal occult blood test.
Chen JG; Cai J; Wu HL; Xu H; Zhang YX; Chen C; Wang Q; Xu J; Yuan XL
World J Gastroenterol; 2012 Jun; 18(21):2682-8. PubMed ID: 22690078
[TBL] [Abstract][Full Text] [Related]
5. Using serum placenta growth factor could improve the sensitivity of colorectal cancer screening in fecal occult blood negative population: A multicenter with independent cohort validation study.
Wei SC; Tsao PN; Wang YT; Lin BR; Wu DC; Tsai WS; Chen JS; Wong JM
Cancer Med; 2019 Jul; 8(7):3583-3591. PubMed ID: 31063258
[TBL] [Abstract][Full Text] [Related]
6. Fecal occult blood test for colorectal cancer screening: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2009; 9(10):1-40. PubMed ID: 23074514
[TBL] [Abstract][Full Text] [Related]
7. Colorectal Cancer Detected by Machine Learning Models Using Conventional Laboratory Test Data.
Li H; Lin J; Xiao Y; Zheng W; Zhao L; Yang X; Zhong M; Liu H
Technol Cancer Res Treat; 2021; 20():15330338211058352. PubMed ID: 34806496
[No Abstract] [Full Text] [Related]
8. Diagnosing colorectal cancer and inflammatory bowel disease in primary care: The usefulness of tests for faecal haemoglobin, faecal calprotectin, anaemia and iron deficiency. A prospective study.
Högberg C; Karling P; Rutegård J; Lilja M
Scand J Gastroenterol; 2017 Jan; 52(1):69-75. PubMed ID: 27623716
[TBL] [Abstract][Full Text] [Related]
9. Optimal diagnostic accuracy of quantitative faecal immunochemical test positivity thresholds for colorectal cancer detection in primary health care: A community-based cohort study.
Pin-Vieito N; García Nimo L; Bujanda L; Román Alonso B; Gutierrez-Stampa MÁ; Aguilar-Gama V; Portillo I; Cubiella J
United European Gastroenterol J; 2021 Mar; 9(2):256-267. PubMed ID: 32778002
[TBL] [Abstract][Full Text] [Related]
10. Biomarker discovery study of inflammatory proteins for colorectal cancer early detection demonstrated importance of screening setting validation.
Qian J; Tikk K; Werner S; Balavarca Y; Saadati M; Hechtner M; Brenner H
J Clin Epidemiol; 2018 Dec; 104():24-34. PubMed ID: 30076979
[TBL] [Abstract][Full Text] [Related]
11. The Relationship between the Methylated Septin-9 DNA Blood Test and Stool Occult Blood Test for Diagnosing Colorectal Cancer in Taiwanese People.
Chen CH; Yan SL; Yang TH; Chen SF; Yeh YH; Ou JJ; Lin CH; Lee YT; Chen CH
J Clin Lab Anal; 2017 Jan; 31(1):. PubMed ID: 27390118
[TBL] [Abstract][Full Text] [Related]
12. Early Detection of Colorectal Cancer: a Multi-Center Pre-Clinical Case Cohort Study for Validation of a Combined DNA Stool Test.
Dollinger MM; Behl S; Fleig WE
Clin Lab; 2018 Oct; 64(10):1719-1730. PubMed ID: 30336540
[TBL] [Abstract][Full Text] [Related]
13. Colorectal cancer in iron deficiency anemia with a positive result on immunochemical fecal occult blood.
Nakama H; Zhang B; Fattah AS; Zhang X
Int J Colorectal Dis; 2000 Nov; 15(5-6):271-4. PubMed ID: 11151429
[TBL] [Abstract][Full Text] [Related]
14. Colorectal cancer and adenoma screening using urinary volatile organic compound (VOC) detection: early results from a single-centre bowel screening population (UK BCSP).
Mozdiak E; Wicaksono AN; Covington JA; Arasaradnam RP
Tech Coloproctol; 2019 Apr; 23(4):343-351. PubMed ID: 30989415
[TBL] [Abstract][Full Text] [Related]
15. New fecal bacterial signature for colorectal cancer screening reduces the fecal immunochemical test false-positive rate in a screening population.
Malagón M; Ramió-Pujol S; Serrano M; Amoedo J; Oliver L; Bahí A; Miquel-Cusachs JO; Ramirez M; Queralt-Moles X; Gilabert P; Saló J; Guardiola J; Piñol V; Serra-Pagès M; Castells A; Aldeguer X; Garcia-Gil LJ
PLoS One; 2020; 15(12):e0243158. PubMed ID: 33259546
[TBL] [Abstract][Full Text] [Related]
16. Systematic review with meta-analysis: faecal occult blood tests show lower colorectal cancer detection rates in the proximal colon in colonoscopy-verified diagnostic studies.
Hirai HW; Tsoi KK; Chan JY; Wong SH; Ching JY; Wong MC; Wu JC; Chan FK; Sung JJ; Ng SC
Aliment Pharmacol Ther; 2016 Apr; 43(7):755-64. PubMed ID: 26858128
[TBL] [Abstract][Full Text] [Related]
17. Evaluating the effects of a risk-adapted screening program for familial colorectal cancer in individuals between 25 and 50 years of age: study protocol for the prospective population-based intervention study FARKOR.
Hoffmann S; Crispin A; Lindoerfer D; Sroczynski G; Siebert U; Mansmann U; Consortium F
BMC Gastroenterol; 2020 May; 20(1):131. PubMed ID: 32370777
[TBL] [Abstract][Full Text] [Related]
18. LGALS4, CEACAM6, TSPAN8, and COL1A2: Blood Markers for Colorectal Cancer-Validation in a Cohort of Subjects With Positive Fecal Immunochemical Test Result.
Rodia MT; Solmi R; Pasini F; Nardi E; Mattei G; Ugolini G; Ricciardiello L; Strippoli P; Miglio R; Lauriola M
Clin Colorectal Cancer; 2018 Jun; 17(2):e217-e228. PubMed ID: 29352642
[TBL] [Abstract][Full Text] [Related]
19. Evidence for improved prognosis of colorectal cancer diagnosed following the detection of iron deficiency anaemia.
Almilaji O; Parry SD; Docherty S; Snook J
Sci Rep; 2021 Jun; 11(1):13055. PubMed ID: 34158616
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of a prediction model for colorectal cancer: retrospective analysis of 2.5 million patient records.
Birks J; Bankhead C; Holt TA; Fuller A; Patnick J
Cancer Med; 2017 Oct; 6(10):2453-2460. PubMed ID: 28941187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
